Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)’s traded shares stood at 0.68 million during the last session, with the company’s beta value hitting 2.29. At the close of trading, the stock’s price was $59.55, to imply an increase of 2.97% or $1.72 in intraday trading. The RYTM share’s 52-week high remains $68.58, putting it -15.16% down since that peak but still an impressive 40.94% since price per share fell to its 52-week low of $35.17. The company has a valuation of $3.76B, with an average of 1.32 million shares in intraday trading volume over the past 10 days and average of 637.37K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Rhythm Pharmaceuticals Inc (RYTM), translating to a mean rating of 1.00. Of 5 analyst(s) looking at the stock, 0 analyst(s) give RYTM a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 5 recommend it as a Buy.
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) trade information
After registering a 2.97% upside in the last session, Rhythm Pharmaceuticals Inc (RYTM) has traded red over the past five days. The 5-day price performance for the stock is 26.84%, and 18.53% over 30 days. With these gigs, the year-to-date price performance is 6.38%. Short interest in Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) saw shorts transact 4.71 million shares and set a 8.39 days time to cover.
The extremes give us $64 and $80 for target low and target high price respectively. As such, RYTM has been trading -34.34% off suggested target high and -7.47% from its likely low.
RYTM Dividends
Rhythm Pharmaceuticals Inc has its next earnings report out on 2025-Feb-25. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)’s Major holders
Rhythm Pharmaceuticals Inc insiders hold 0.54% of total outstanding shares, with institutional holders owning 107.77% of the shares at 108.36% float percentage. In total, 107.77% institutions holds shares in the company, led by PRIMECAP MANAGEMENT CO/CA/. As of 2024-06-30, the company held over 7.31 million shares (or 11.9852% of shares), all amounting to roughly $300.25 million.
The next major institution holding the largest number of shares is BLACKROCK INC. with 6.74 million shares, or about 11.0502% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $276.82 million.
We also have PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Rhythm Pharmaceuticals Inc (RYTM) shares. Going by data provided on Jan 31, 2025 , PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund holds roughly 4.45 shares. This is just over 7.03% of the total shares, with a market valuation of $264.84 million. Data from the same date shows that the other fund manager holds a little less at 1.9, or 3.01% of the shares, all valued at about 113.22 million.
